Charmaine Chan, PhD, CFA, senior analyst with Cambiar Investors, and Brad Loncar, CEO of Loncar Investments, shared insights on the recent J.P. Morgan 39th Healthcare Conference—the first time the event took place virtually—and the annual state of the life sciences, its successes, and challenges it faces in 2021 during the inaugural episode of “GEN Edge Live,” an occasional series of Zoom-casts focused on the industry. Chan and Loncar were joined on “GEN Edge Live” by Alex Philippidis, GEN Senior Business Editor; Kevin Davies, PhD, GEN Editor at Large; and John Sterling, GEN Editor in Chief for more than three decades.

“GEN Edge Live” will be an important new component of GEN Edge, the premium content tier of Genetic Engineering & Biotechnology News. “GEN Edge Live” is produced by Genetic Engineering & Biotechnology News, and calls itself the program “Where GEN gets down to business.” Watch “GEN Edge Live” and hear the entire conversation on demand via YouTube.

Previous articleHIV Drugs May Be Repurposed for Blindness
Next articlePaper-like Medical Tapes Developed That Transform into Soft, Strong Adhesives Internally